Seres Therapeutics
NASDAQ: MCRBCambridge, US · Founded 2010 · 109 employees on LinkedIn · 3 known investors
Seres Therapeutics is a clinical-stage biotechnology company developing therapies composed of rationally selected live bacterial consortia to treat serious diseases through modulation of the human microbiome. The company pioneered the development and FDA approval of VOWST, an oral live biotherapeutic.
Founders & leadership
MH
Matthew HennPresident and Chief Scientific Officer
Investors · 3
Founder mafia
2 people who came through Seres Therapeutics went on to found or lead other companies.
Competitors · 2
by search overlap
Robinhood25 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Sarepta Therapeutics24 shared keywordsSarepta develops precision genetic medicines for people with rare diseases, with a focus on rare neuromuscular conditions. The company also runs an investigator-initiated studies program that funds independent clinical and non-clinical research in its therapeutic areas.
Companies competing with Seres Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Seres Therapeutics do?
- Seres Therapeutics is a clinical-stage biotechnology company developing therapies composed of rationally selected live bacterial consortia to treat serious diseases through modulation of the human microbiome. The company pioneered the development and FDA approval of VOWST, an oral live biotherapeutic.
- Who are Seres Therapeutics's investors?
- Seres Therapeutics's investors include Flagship Pioneering, RA Capital, Sofinnova Ventures.
- Where is Seres Therapeutics headquartered?
- Seres Therapeutics is headquartered in Cambridge, US.